SURUNKALI OBSTRUKTIV O‘PKA KASALLIGIDA IMMUNOGENETIK MARKERLARNING PROGNOSTIK AHAMIYATI VA PERSONALIZATSIYALANGAN BAHOLASH
Keywords:
Kalit so‘zlar: SO‘OK, prognoz, immunogenetik marker, FEV1, eozinofiliya, zo‘rayish, SERPINA1, MMP9, IL-6, personalizatsiyalangan tibbiyot.Abstract
Annotatsiya. Surunkali obstruktiv o‘pka kasalligining klinik kechishi bemorlar o‘rtasida sezilarli darajada farq qiladi. Ayrim bemorlarda o‘pka funksiyasi sekin pasaysa, boshqalarida tez-tez zo‘rayishlar, emfizema va nafas yetishmovchiligi rivojlanishi mumkin. Ushbu heterogenlikni tushuntirishda immunologik va genetik omillar muhim o‘rin tutadi. Immunogenetik markerlarni klinik va funksional parametrlar bilan birlashtirish SO‘OKning progressiyasi va zo‘rayish xavfini individual baholash uchun istiqbolli yo‘nalish hisoblanadi.
References
1.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD. 2026 Report.
2.Cazzola M., Bajpai J., Calzetta L. et al. GOLD 2026: Transforming COPD Management with Early Intervention, Multi-dimensional Assessment, and Personalized Care. Drugs. 2026.
3.Milne S., Sin D.D. Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine. Clin Chest Med. 2020;41(3):383–394.
4.Clinical and molecular markers in COPD. Pulmonology.
5.McCloskey S.C., Jones S.E., Hind C.R.K. et al. The role of genetic susceptibility in chronic obstructive pulmonary disease.
6.Silverman E.K., Sandhaus R.A. Alpha1-antitrypsin deficiency. N Engl J Med.